Biotoxtech ranked among the top searched stocks on 2 days within the past month.


As of 2:30 PM on the 23rd, Biotoxtech is trading at 17,500 KRW, up 11.46% from the previous day. This represents a 65.09% increase compared to October 30. Biotoxtech is known as a leading domestic CRO company specializing in non-clinical trials.

Over the past 5 days, individual investors have net purchased 61,206 shares, while foreigners and institutions have net sold 66,630 shares and net purchased 150 shares, respectively.


On November 19, Biotoxtech became a market issue with the news of 'Second largest shareholder Celltrion's increased possibility of contract manufacturing Pfizer vaccines.'



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing